RAD21 overexpression was implicated in different types of cancers including colorectal22, lung23, cervical24 ovarian25 prostate26 and breast cancer, where RAD21 overexpression was reported to confer poor prognosis and resistance to chemotherapy in HER2 mutant breast cancer patients27. Here, ERBB2 is linked to breast carcinoma.